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Abstract 
Myelodysplatic syndrome (MDS) with an isolated 
5q deletion (5q-syndrome), that may arise de novo or 
may be therapy-related is recognized as a distinct 
entity by the WHO classification. While del(5q) 
thought to contribute to the pathogenesis of myeloid 
neoplasms, it has also been reported in 
lymphoblastic leukemia, suggesting a common 
underlying mechanism. 
Keywords 
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Identity 
See Figure 1. 
Clinics and pathology 
Disease 
Acute lymphoblastic leukemia 
Etiology 
Acute leukemia evolving from an underlying MDS 
with del(5q) is almost always of myeloid lineage and 
only anecdotal case reports of MDS transforming to 
ALL have been reported (Agostino et al., 2011; Jain 
et al., 2016). Whether the presence of del(5q) in 
these cases reflects the underlying myelodysplastic 
state that later evolved into ALL remains unclear. 
del(5q) in ALL is mostly associated with multiple 
cytogenetic abnormalities that thought to be due to 
clonal expansion from an abnormal pluripotent stem 
cell. 
Figure 1.  (A). Fluorescence in situ hybridization with Vysis LSI CSF1R (5q33-34)/5p15.2 probe (Abott Molecular/Vysis, US) 
showing 2 red and 2 green signals on a normal metaphase and only 1 red signal on a metaphase with 5q deletion. Inset: Partial 
karyotype with 5q deletion and with chromosome 5 in 'action' (chromosome 5 breaks). 
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Epidemiology 
At least 160 reported patients aged 0 to 86 years (98 
males, 61 females, 1 unknown); prevalence of 
pediatric patients (86 patients) and there were 46 
adults.  
B-cell acute lymphoblastic leukemia:  70 patients 
aged 0 to 86 years (41 males and 28 females, 1 
unknown); among them there were 22 adults (14 
males and 8 females, aged 22 to 86 years; median 42 
years) and 39 pediatric patients (22 males and 17 
females, aged 0 to 18; median 6 years). In addition, 
there were 9 patients with unknown age (5 males and 
3 females, 1 unknown).  
T-cell acute lymphoblastic leukemia:  58 patients 
(35 males and 23 females aged 1 to 79 years); among 
them there were 17 adults (9 males and 8 females 
aged 19 to 79 years), 35 pediatric patients (22 males 
13 females aged 1 to 18 years) and 6 patients with 
unknown age (4 males and 2 females).  
32 patients had unspecified ALL (22 males, 10 
females aged 3 to 81 years; median 13 years); 7 
patients were adults (5 males and 2 females) aged 34 
to 81 years (median 72 years), 12 were pediatric 
patients (8 males and 4 females aged 3 to 16 years; 
median 6 years) and there were 12 patients with 
unknown age (8 males and 4 females). 
Clinics 
In contrast to its presence in myeloid malignancies, 
isolated del(5q) is rare in ALL, thus its clinical 
significance is unknown. del(5q) also appears to be 
clinically insignificant in patients following 
cytotoxic therapy or tyrosine kinase inhibitor (TKI) 
therapy, similar to other clonal cytogenetic 
abnormalities if detected as a minor clone (Tang et 
al., 2015). del(5q) in ALL mainly found  as a clonal 
evolution event associated with disease progression. 
Genetics 
Del(5q) may be found as sole abnormality at first, as 
an evolutionary event in other cases, and as a 
transient event in patients after being treated with 
cytotoxic agents or TKI for the prior malignancies. 
Cytogenetics 
Cytogenetics morphological 
Excluded are patients with EBF1/PDGFRB 
fusion that arose from interstitial deletion of 5q33, 
occurring within the Philadelphia-like ALL subtype.  
Del(5q) as a sole clonal cytogenetic abnormality  
was found in 11 patients (3 with B-ALL, 4 with T-
ALL and 4 with unspecified ALL) (Kowalczyk et al., 
1985; Brusamolino et al., 1988; Raimondi et al., 
1988; Loncarevic et al., 1999;  Midmer et al., 1999; 
Gmidene et al., 2008; Palau et al., 1991; Valtat et al., 
1991; Theodossiou et al., 1992; Goud et al., 2015). 
Among these patients, there was and a 5-year-old 
boy who had previously received chemotherapy for 
ALL that had been diagnosed nine months before 
(Palau et al., 1991), a 13-year-old boy in whom the 
rearrangement was transiently present 7 months 
following the diagnosis of Ph-positive ALL 
(Theodossiou et al., 1992).  
Del(5q)with other abnormalities Found in a 
sideline with del(20q) and +Y in 2 MDS patients 
transforming to B-ALL while on lenalidomide 
(Agostino et al., 2011) and with limited additional 
anomalies such as i(7)(q10) in 1 (Kaneko et al., 
1989), +22 in 1 (Karst et al., 2006), 
der(19)t(1;19)(q23;p13) in 1 (Chen et al., 1992) and 
1 had a clone with a Ph chromosome and del(5q) at 
diagnosis (Takechi et al., 1990). The 
t(12;21)(p13;q22) was present as a sole additional 
anomaly in 3 patients with B-cell ALL (Lu et al., 
2002;  South et al., 2006; Zhou et al., 2012) and in 8 
it was part of a complex karyotype (Alvarez et al., 
2005; Kuchinskaya et al., 2005; Jarosova et al., 
2003; Martineau et al., 2005;  Olsson et al., 2018), 
however it is possible that some additional pediatric 
patients had a cryptic t(12;21). 3 patients had 
dic(9;20) (Heerema et al., 1996; Strefford et al., 
2007;  An et al., 2008), 10 t(9;22) (q34;q11) 
(Sessarego et al., 1991; Tsuchiya et al., 1995; Rieder 
et al., 1996; Lee et al., 2002; Onciu et al., 2002; 
Wetzler et al., 2004; Russell et al., 2008; De 
Braekeleer et al., 2010; Lundin et al., 2014; Olsson 
et al., 2018) in complex karyotypes. The majority of 
patients with T-ALL had karyotypes with 
combination of chromosome deletions and specific 
translocations such as t(4;11)(q21;p15) (Hussey et 
al., 1999), t(5;14)/HOX11L2 (Berger et al., 2003;  
Bernard et al., 2001), t(4;11)(q23;p15) (Zhang et al., 
2012), t(7;10)(q34;q24) (Lai et al., 2000), 
t(7;11)(q35;p13) (Kaneko et al. ID: >1998), 
t(10;11)(p12;q21) (Matlawska-Wasowska et al., 
2016), t(10;14)(q24;q11) (Grossmann et al., 2013) 
and inv(7)(p15q34) (Rowley et al., 1999; La Starza 
et al., 2016). 
Genes involved and 
proteins 
Deletions of 5q are heterozygous, and deleted 
regions can affect different genes that are involved 
in the regulation of hematopoiesis. 
Result of the chromosomal 
anomaly 
Fusion protein 
Oncogenesis 
Interstitial or terminal deletions of the long arm of  
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chromosome 5 are common findings in MDS or 
acute myeloid leukemia (AML), but they may also 
occur in patients with ALL. Deletions of genetic 
material from 5q result in loss of tumor suppressor 
genes that may potentially play a role in the 
pathogenesis of these diseases. The long arm of 
chromosome 5 contains many genes that are relevant 
in hematopoiesis and several candidate genes 
including transcription factors, cytokines and their 
receptors, signal mediators and cell cycle regulators 
have been identified. These include the RPS14 gene 
on 5q33.1, a critical gene for the erythroid 
phenotype, a microRNA cluster on 5q32-33 
important for the megakaryocytic phenotype, the 
EGR1 gene on 5q31 that plays a role in 
hematopoietic stem cell proliferation. Other genes 
such as NPM1 and APC, the transcription factor 
Egr1/Krox20, the cytoskeletal remodeling protein, 
alpha-catenin may also contribute to the disease 
phenotype and progression (Tang et al., 2015). 
Although a critical tumor suppressor gene has not yet 
been identified in ALL, several putative tumor 
suppressors such as NR3C1 and TCF7, located 
within the 5q31 common deleted region and 
TRIM41, ZFP62, MAPK9, MGAT1, and CNOT6, 
mapping at 5q35 have been found to be down-
regulated in T- ALL (La Starza et al.,2016). Given 
the large size and variable pattern of 5q deletions, it 
is probable that the loss of several genes that act 
alone or in combination contribute to pathogenesis. 
The absence of a clear critical gene suggests that 
deletion of variable combinations of genes may 
result in a clinical spectrum ranging from myeloid 
malignancies to lymphoid leukemia. 
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